newsfilter
← Latest News
GlobeNewswire·

POINT Biopharma Reports First Quarter 2023 Financial Results and Provides Business Highlights

U.S. FDA granted Fast Track designation for 177Lu-PNT2002 for the treatment of mCRPC in April 2023 Announces $10 million strategic investment in commercial-scale alpha-emitting isotope manufacturer, Ionetix Alpha Corp.